Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
- Citation:
- Breast Cancer Res Treat vol 98 (2) 217-22
- Year:
- 2006
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- James N Ingle
- Authors:
- James N Ingle Vera J Suman James A Mailliard John W Kugler James E Krook John C Michalak Thomas M Pisansky Lester E Wold John H Donohue Matthew P Goetz Edith A Perez
- Networks:
- Study
- NCCTG-89-30-52
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Breast Neoplasms, Disease-Free Survival, Female, Fluoxymesterone, Humans, Middle Aged, Postmenopause, Receptors, Estrogen, Tamoxifen